PMEL and melanoma: Electroporation-facilitated DLnano-vaccines that scaffold immunodominant melanoma Gp100 and Trp2 epitopes were shown to induce more potent and consistent epitope-specific cytolytic T cell responses than were the corresponding DNA monomeric vaccines or CpG-adjuvanted peptide vaccines (17).